CHESTERBROOK, Penn. – The U.S. Food and Drug Administration has given clearance to a diabetes management solution that integrates LifeScan’s OneTouch Verio Flex blood glucose monitoring system with WellDoc Inc.’s clinically validated management platform, BlueStar. The new solution will provide patients with Type 2 diabetes with individualized real-time feedback and virtual coaching based on the patient’s specific treatment plan, and also help health care teams make timely diabetes management decisions. The OneTouch Verio Flex meter also has optional wireless connectivity with the OneTouch Reveal mobile app. LifeScan and WellDoc are currently working with health plans to help provide patient access to the integrated system.
You are here: / / LifeScan, BlueStar integration receives FDA clearance